Based on Offerings, the market is divided into products and services segments. The products segment accounted for the largest share of the next-generation sequencing market in 2023. The large share of ...
Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...
Oct 9 (Reuters) - Medical equipment maker Illumina (ILMN.O), opens new tab announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to ...
Illumina fundamentals are improving, with FY26 expected to return to positive growth and enable operating leverage. Find out ...
On Monday, Illumina, Inc. (NASDAQ:ILMN) agreed to acquire Standard BioTools’ (NASDAQ:LAB) subsidiary, SomaLogic. Following the announcement of the acquisition, Standard BioTools’ stock experienced a ...
Next-generation sequencing (NGS) has moved away from expensive runs and complicated workflows into a new era where benchtop instruments prioritize sustainability, accessibility, accuracy, and speed.
Agreement grants access to Synaffix patent portfolio related to metal-free click chemistry Technology to be used in Illumina's next-generation sequencing (NGS) products AMSTERDAM, Dec. 4, 2024 ...
KANNAPOLIS — Catawba College and Eremid Genomic Services are now accepting applications for a unique summer program: Illumina Next Generation Sequencing Workshop and Certificate Program from Aug. 5-16 ...
SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...
Illumina, Inc. ILMN recently launched the Global Health Access Initiative to support the acceleration of pathogen sequencing in low and middle-income countries (LMICs). The program aims to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results